Glaxosmithkline Share News (GSK)

UPDATE 1-More foreign pharmaceutical firms could be probed in China-Xinhua

By Michael Martina BEIJING, July 24 (Reuters) - China's official news agency hinted that more foreign pharmaceutical firms could soon be implicated in a corruption scandal sweeping the industry, in the wake of bribery accusations against British drugmaker GlaxoSmithKline. "It will not

UPDATE 2-GSK warns China corruption scandal will hit business

* Too early to quantify sales hit in China from bribery case * CEO remains highly committed to China, will still invest * Considering adopting more tiered pricing in China * Q2 sales 6.62 bln pounds vs consensus 6.60 bln * Q2 EPS 26.3 pence vs consensus 26.2p By Ben

Novartis vaccine division hit by Bexsero setback

* Bexsero is first approved vaccine in Europe for MenB * UK committee advises against inclusion in vaccine programme * Committee cites cost concerns as main reason * Novartis to submit pricing information before final decision ZURICH, July 24 (Reuters) - Swiss drugmaker No

London midday: Markets boosted by earnings, Eurozone PMIs

Upbeat corporate earnings from a number of heavyweights and improving data in the Eurozone gave UK markets a boost on Wednesday morning, as traders shrugged off concerns about manufacturing activity in China. easyJet, ARM Holdings, Tate & Lyle, Kingfisher and Compass were all trading firmly higher

UPDATE 1-GlaxoSmithKline sees hit from China corruption scandal

By Ben Hirschler LONDON, July 24 (Reuters) - Drugmaker GlaxoSmithKline , rocked by charges of corruption in China, reported a modest 2 percent rise in second-quarter group sales on Wednesday but said the bribery scandal would inevitably have an impact. "Clearly, we are likely to see s

South Africa's Aspen Pharmacare values GSK deal at 700 mln pounds

JOHANNESBURG, July 24 (Reuters) - South Africa's Aspen Pharmacare Holdings on Wednesday valued its bid for two of GlaxoSmithKline's thrombosis drugs and a French factory at around 700 million pounds sterling, 100 million pounds of which will be for inventory. The proposed deal was announced

GlaxoSmithKline sees hit from China corruption scandal

LONDON, July 24 (Reuters) - Drugmaker GlaxoSmithKline , rocked by charges of corruption in China, reported a modest 2 percent rise in group sales on Wednesday but said the bribery scandal would inevitably have an impact. "Clearly, we are likely to see some impact to our performance in China

More pharmaceutical firms could soon be investigated in China-Xinhua

More pharmaceutical firms could soon be investigated in China-Xinhua

By Michael Martina BEIJING, July 24 (Reuters) - China's official news agency hinted that more foreign and local pharmaceutical firms could soon be implicated in a corruption scandal sweeping the industry, in the wake of bribery accusations against British drugmaker GlaxoSmithKline. Th

British watchdog rejects GSK's lupus drug again

LONDON, July 24 (Reuters) - Britain's healthcare cost watchdog has rejected GlaxoSmithKline's lupus drug Benlysta a second time after the company offered an undisclosed discount, saying it still failed to offer good value for money. The National Institute for Health and Care Excellence (NIC

London open: Markets rise as earnings impress

Well-received updates and results from easyJet, ARM Holdings, Tate & Lyle, Compass and Kingfisher pushed the FTSE 100 firmly into positive territory on Wednesday morning, as markets shrugged off disappointing economic data from China. HSBC's flash China manufacturing purchasing managers' index (PMI

Wednesday newspaper round-up: RBS, AstraZeneca

Royal Bank of Scotland is expected to announce a new Chief Executive to replace outgoing boss Stephen Hester, as early as next week, The Telegraph revealed. Two more AstraZeneca sales executives have been arrested by Chinese police in relation to nation-wide investigation into the drugmaking indus

UPDATE 3-U.S. citizen detained as China pharma probe spreads

* U.S. citizen held amid widening China pharma probe * Two more Chinese staff at AstraZeneca questioned * 39 hospital staff to be punished for taking bribes-Xinhua * Industry under scrutiny after bribery charges against GSK * GSK reports second-quarter results at 1100 GMT<

Bribery serves as life-support for Chinese hospitals

* Low salaries foster widespread bribery in public hospitals * State fixes cost of hospital operations and caps drug prices * Leaves public hospitals with little room to top up doctors' pay * Britain's GlaxoSmithKline embroiled in bribery scandal By Kazunori Takada S

UPDATE 2-First U.S. citizen detained as China pharma probe spreads

* U.S. citizen held amid widening China pharma probe * Two more Chinese staff at AstraZeneca questioned * Industry under scrutiny after bribery charges against GSK * 39 hospital staff to be punished for taking bribes-Xinhua By Michael Martina BEIJING, July 23 (Reuter